Early Access to Medicines Scheme: real-world data collection

被引：3

作者：

Pang, Hok ^{[1
]}

Wang, Meng ^{[1
]}

Kiff, Christopher ^{[1
]}

Soni, Mira ^{[2
]}

Stein, Dara ^{[2
]}

Tyas, David ^{[1
]}

机构：

[1] Bristol Myers Squibb Pharmaceut Ltd, London, England

[2] Evidera, London, England

来源：

DRUG DISCOVERY TODAY | 2019年 / 24卷 / 12期

关键词：

D O I：

10.1016/j.drudis.2019.06.009

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Real-world data (RWD) generated during the pre-approval phase could be supplementary to primary clinical trial outcomes; however, as we discuss here, a data collection framework is needed to ensure the validity and applicability of these data.

引用

页码：2231 / 2233

页数：3

共 50 条

[21] Challenges in data collection in real-world environments for activity recognition
Lameski, Petre
Dimitrievski, Ace
Zdravevski, Eftim
Trajkovik, Vladimir
Koceski, Saso
PROCEEDINGS OF 18TH INTERNATIONAL CONFERENCE ON SMART TECHNOLOGIES (IEEE EUROCON 2019), 2019,
[22] Real-world study: from real-world data to real-world evidence
Wen, Yi
TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
[23] From an early access program to real-world cenobamate use
Thomas, R.
EPILEPSIA, 2023, 64 : 4 - 5
[24] Translating real-world evidence/real-world data
Ravenstijn, Paulien
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):
[25] Real-World Data: Policy Issues Regarding their Access and Use
Basu, Anirban
Axelsen, Kirsten
Grabowski, David C.
Meltzer, David O.
Polsky, Daniel
Ridley, David B.
Wiederkehr, Daniel
Philipson, Tomas J.
MEDICAL CARE, 2016, 55 (12) : 1038 - 1044
[26] Real-world data on access to SoC for the SMA population in the UK
Muni-Lofra, R.
Murphy, L.
Adcock, K.
Farrugia, M.
Irwin, J.
Lilleker, J.
McConville, J.
Merrison, A.
Parton, M.
Ryburn, L.
Scoto, M.
Marini-Bettolo, C.
Mayhew, A.
NEUROMUSCULAR DISORDERS, 2021, 31 : S128 - S129
[27] RISANKIZUMAB FOR REFRACTORY CROHN'S DISEASE: REAL WORLD EXPERIENCE FROM A PRE-APPROVAL ACCESS PROGRAM & EARLY ACCESS TO MEDICINES SCHEME
Zare, Benjamin
Lal, Natasha
Dawson, Patrick
Sharma, Esha
Dart, Robin
Lim, Samuel
Ray, Shuvra
Anderson, Simon
Mawdsley, Joel
Irving, Peter
Samaan, Mark
GUT, 2023, 72 (SUPPL_2) : A16 - A17
[28] UTILITY OF EARLY ACCESS TO MEDICINES SCHEME DATA FOR NICE DECISION-MAKING
Brett, A.
Umeweni, N.
McCracken, F.
VALUE IN HEALTH, 2019, 22 : S725 - S725
[29] EARLY ACTIVATION OF VALUE DEMONSTRATED BY THE COLLECTION OF REAL WORLD DATA IN PRE-APPROVAL ACCESS SETTINGS
Eslami, N.
Zaidi, Q.
Sadana, R.
Garfield, S.
Richardson, S.
VALUE IN HEALTH, 2019, 22 : S343 - S343
[30] Real-world data collection in Niemann-Pick disease type C: Data from expanded access program with arimoclomol
Berry-Kravis, Elizabeth
Gallo, Daniel
Pagano, Kristin
Donnelly, Conan B.
MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)

← 1 2 3 4 5 →